Flowable hemostats have flowable consistency and contain a porcine or bovine gelatin matrix. It may add topical thrombin. When an application is needed on a difficult reach surface or in a wet field flowable hemostats are helpful. The product can be used for all surgical procedures except ophthalmic.
Baxter International and Ethicon (Johnson and Johnson Services, Inc.) – Notable Market Players in Flowable Hemostats Market
The flowable hemostats market is majorly comprised of top players involving Baxter International, Ethicon (Johnson and Johnson Services, Inc.), Pfizer Inc., Teleflex Incorporated, B. Barun, BD, SYMATESE amongst others.
The companies listed above are implementing various strategies that have resulted in the growth of the company and in turn, have brought about various changes in the Europe, China, and Japan market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
Below is the list of the growth strategies done by the players operating in the flowable hemostats market:
| Year | News |
| Jun-2022 | BD (Becton, Dickinson and Company) announced a collaboration with Mayo Clinic Platform to access de-identified patient data from Mayo Clinic Platform. Discover to perform detailed post-market surveillance on its products to fuel innovation and unlock a faster, more efficient path to market, with the ultimate goal of improving patient care. |
| Jul-2021 | Baxter International Inc. announced its Baxter Healthcare Corporation subsidiary had completed the acquisition of certain assets related to PerClot Polysaccharide Hemostatic System from CryoLife, Inc. The transaction reinforces Baxter’s strategy of acquiring products and technologies that both complement and augment the company’s leading portfolio across the hospital, including in the operating room. |
| Feb-2021 | Teleflex Inc. recently acquired Z-Medica LLC, an industry-leading manufacturer of hemostatic products. Z-Medica is a medical device manufacturer focused on developing innovative hemorrhage control products. This acquisition enhanced company’s hemostats product portfolio. |
| Mar-2019 | Baxter International Inc. announced it had completed its acquisition of two hemostat and sealant products from Mallinckrodt plc. RECOTHROM Thrombin topical (Recombinant) is the first and only stand-alone recombinant thrombin and PREVELEAK Surgical Sealant is used in vascular reconstruction. Both products complement and broaden Baxter’s existing surgical portfolio of hemostats and sealants. |
